← Browse by Condition
Medical Condition
plaque psoriasis
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2
NCT06382987
Recruiting
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
Enrollment
600 pts
Location
Japan
Sponsor
Bristol-Myers Squibb
NCT06382051
Recruiting
Modifying PEST for Psoriatic Arthritis Screening
Enrollment
502 pts
Location
Canada
Sponsor
Novartis Pharmaceuticals
NCT07039110
Recruiting
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Enrollment
700 pts
Location
Canada, Czechia, Fra...
Sponsor
AbbVie
NCT07449702 Phase 2
Recruiting
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Enrollment
80 pts
Location
United States, Canad...
Sponsor
Oruka Therapeutics, Inc.
NCT07024602 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
Enrollment
94 pts
Location
United States
Sponsor
Ascletis Pharma (China) Co., L...
NCT07129382 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Enrollment
220 pts
Location
China
Sponsor
Chipscreen Biosciences, Ltd.